Home » Newsletters » BioWorld Science

BioWorld Science

May 6, 1997

View Archived Issues

Pfizer's CP-148623 lowers serum cholesterol in humans

Results from analysis of 10 years of amiodarone therapy presented

Sanofi claims HLE inhibitors

Pharma Mar isolates new cytotoxic agents from marine sponge

Squalene synthase inhibitors reported by Takeda

AMPA/NMDA receptor antagonists from Rhone-Poulenc Rorer

Kaneka discloses anti-H. pylori rifamycins

Prokinetic agents from Kyorin

Cyclic hexapeptide antitumor agents described by Taisho

Daiichi and Fuji prepare new analgesics

Gilead's cidofovir injection approved in the European Union

OraVax: Q1 1997 highlights

Biosource Technologies awarded NIH grant to develop melanin as an antiinflammatory compound

Neurotrophic factor gene therapy shows promise for motor neuron diseases

Chiron and DepoTech complete NDA for DepoCyt

AGM-1470 may have potential for controlling fertility

Progress report on Cypros's adenosine and neuronal calcium channel preclinical programs

ABT-431 evaluated in Parkinson's patients

Hybridon and the Institute of Human Virology enter antisense AIDS therapy collaboration

SIBIA identifies biochemical marker for Alzheimer's disease

Clinical efficacy of Myotrophin in ALS and postpolio syndrome

Salix to commence clinical trials with Normix

Rhone-Poulenc Rorer licenses Granocyte for additional countries

Cytel and Schwarz terminate research collaboration

Neuromyalgic response to rhNGF described

Helix BioPharma enters research and development agreement

FDA grants SciClone orphan drug status for CPX

FDA clears generic version of SKB's Compazine

Transdermal N-0923 effective in Parkinson's disease

COX-2 inhibitor shows potential for preventing neuronal death

Preclinical studies with sodium channel blockers in traumatic brain injury

BioCryst commences phase I trial of HIV compound

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...